Cargando…
mFOLFOX6 Chemotherapy after Resection of Anal Canal Mucinous Adenocarcinoma
Because of their rarity, there are no clear guidelines for the treatment of anal carcinomas; such tumors are normally subjected to the same modalities as recommended for rectal cancer. We report a patient with anal canal mucinous adenocarcinoma, with metastases in the pararectal and right inguinal l...
Autores principales: | Matsunaga, Mototsugu, Miwa, Keisuke, Oka, Yosuke, Nagasu, Sachiko, Sakaue, Takahiko, Fukahori, Masaru, Ushijima, Tomoyuki, Akagi, Yoshito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881242/ https://www.ncbi.nlm.nih.gov/pubmed/27239184 http://dx.doi.org/10.1159/000446066 |
Ejemplares similares
-
Successful Treatment of Metastatic Anal Canal Adenocarcinoma with mFOLFOX6 + Bevacizumab
por: Matsunaga, Mototsugu, et al.
Publicado: (2016) -
Successful Treatment with S-1 and Oxaliplatin Combination Therapy in an Elderly Patient with Metastatic Colorectal Cancer Initially Presenting with Membranous Nephropathy
por: Matsunaga, Mototsugu, et al.
Publicado: (2015) -
Cediranib with mFOLFOX6 vs bevacizumab with mFOLFOX6 in previously treated metastatic colorectal cancer
por: Cunningham, D, et al.
Publicado: (2013) -
Hyperlipidemia as a risk factor for Trousseau syndrome-related cerebral infarction in patients with advanced gastrointestinal cancer
por: Tanaka, Toshimitsu, et al.
Publicado: (2022) -
Two Patients with Dry Eye Disease Followed Up Using an Expression Assay of Ocular Surface Mucin
por: Machida, Yumiko, et al.
Publicado: (2016)